Floatz logo

Pioglitazone

Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Seung Up KimSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes cohort.

Asset / SponsorPhaseRating
Evogliptin
Seung Up Kim
Phase 4BB

Same molecule, other indications

Pioglitazone is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →